Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evoke Pharma, Inc. - Common Stock (NQ:EVOK)

3.489 -0.331 (-8.67%)
Streaming Delayed Price Updated: 3:48 PM EDT, Mar 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 48,233
Open 3.820
Bid (Size) 3.290 (3)
Ask (Size) 3.490 (1)
Prev. Close 3.820
Today's Range 3.320 - 3.820
52wk Range 3.320 - 12.32
Shares Outstanding 3,343,070
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For March 13, 2025
Via Benzinga
Why Evoke Pharma (EVOK) Stock Is Volatile
Evoke Pharma shares were trading lower by 21.4% during Tuesday's session. The company announced a 1-for-12 reverse stock split of its common stock. 
Via Benzinga

Performance

YTD
-22.0%
-22.0%
1 Month
-33.5%
-33.5%
3 Month
-24.0%
-24.0%
6 Month
-17.3%
-17.3%
1 Year
-53.1%
-53.1%

More News

Read More
Recap: Evoke Pharma Q4 Earnings
Via Benzinga
A Preview Of Evoke Pharma's Earnings
Via Benzinga
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
S&P 500 Moves Higher; Philips Shares Plunge After Q3 Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Dow Jumps Over 300 Points; ON Semiconductor Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Evoke Pharma Stock Is Soaring Monday: What's Going On?
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
EVOK Stock Earnings: Evoke Pharma Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
EVOK Stock Earnings: Evoke Pharma Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
EVOK Stock Earnings: Evoke Pharma Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why VCI Global Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is Evoke Pharma, Inc. - Common Stock publicly traded?
Yes, Evoke Pharma, Inc. - Common Stock is publicly traded.
What exchange does Evoke Pharma, Inc. - Common Stock trade on?
Evoke Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Evoke Pharma, Inc. - Common Stock?
The ticker symbol for Evoke Pharma, Inc. - Common Stock is EVOK on the Nasdaq Stock Market
What is the current price of Evoke Pharma, Inc. - Common Stock?
The current price of Evoke Pharma, Inc. - Common Stock is 3.489
When was Evoke Pharma, Inc. - Common Stock last traded?
The last trade of Evoke Pharma, Inc. - Common Stock was at 03/17/25 03:48 PM ET
What is the market capitalization of Evoke Pharma, Inc. - Common Stock?
The market capitalization of Evoke Pharma, Inc. - Common Stock is 11.66M
How many shares of Evoke Pharma, Inc. - Common Stock are outstanding?
Evoke Pharma, Inc. - Common Stock has 12M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.